Access to Vaccination among Disadvantaged, Isolated and Difficult-to-Reach Communities in the WHO European Region: A Systematic Review

Abstract

Vaccination has a significant impact on morbidity and mortality. High vaccination coverage rates are required to achieve herd protection against vaccine-preventable diseases. However, limited vaccine access and hesitancy among specific communities represent significant obstacles to this goal. This review provides an overview of critical factors associated with vaccination among disadvantaged groups in World Health Organisation European countries. Initial searches yielded 18,109 publications from four databases, and 104 studies from 19 out of 53 countries reporting 22 vaccine-preventable diseases were included. Nine groups representing the populations of interest were identified, and most of the studies focused on asylum seekers, refugees, migrants and deprived communities. Recall of previous vaccinations received was poor, and serology was conducted in some cases to confirm protection for those who received prior vaccinations. Vaccination coverage was lower among study populations compared to the general population or national average. Factors that influenced uptake, which presented differently at different population levels, included health service accessibility, language and vaccine literacy, including risk perception, disease severity and vaccination benefits. Strategies that could be implemented in vaccination policy and programs were also identified. Overall, interventions specific to target communities are vital to improving uptake. More innovative strategies need to be deployed to improve vaccination coverage among disadvantaged groups.

Publication DOI: https://doi.org/10.3390/vaccines10071038
Divisions: College of Business and Social Sciences > School of Social Sciences & Humanities > Sociology and Policy
Funding Information: The ImmuHubs project is co-funded by European Union’s Health Programme (2014–2020) and coordinated by the Vienna Vaccine Safety Initiative (www.vi-vi.org, accessed on 13 June 2022), in collaboration with academic institutions, NGOs and public health agenc
Additional Information: Copyright © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Funding Information: The ImmuHubs project is co-funded by European Union’s Health Programme (2014–2020) and coordinated by the Vienna Vaccine Safety Initiative (www.vi-vi.org, accessed on 13 June 2022), in collaboration with academic institutions, NGOs and public health agencies in Europe as well as the European Academy of Paediatrics and the European Parents’ Association.
Uncontrolled Keywords: disadvantaged groups,Europe,health services,immunisation programs,inequalities,migration,vaccination,Immunology,Pharmacology,Drug Discovery,Infectious Diseases,Pharmacology (medical)
Publication ISSN: 2076-393X
Last Modified: 18 Nov 2024 08:47
Date Deposited: 20 Nov 2023 15:25
Full Text Link:
Related URLs: http://www.scop ... tnerID=8YFLogxK (Scopus URL)
https://www.mdp ... -393X/10/7/1038 (Publisher URL)
PURE Output Type: Review article
Published Date: 2022-07-01
Published Online Date: 2022-06-28
Accepted Date: 2022-06-14
Authors: Ekezie, Winifred (ORCID Profile 0000-0001-6622-0784)
Awwad, Samy
Krauchenberg, Arja
Karara, Nora
Dembiński, Łukasz
Grossman, Zachi
Torso, Stefano Del
Dornbusch, Hans Juergen
Neves, Ana
Copley, Sian
Mazur, Artur
Hadjipanayis, Adamos
Grechukha, Yevgenii
Nohynek, Hanna
Damnjanović, Kaja
Lazić, Milica
Papaevangelou, Vana
Lapii, Fedir
Stein-Zamir, Chen
Rath, Barbara

Download

[img]

Version: Published Version

License: Creative Commons Attribution

| Preview

Export / Share Citation


Statistics

Additional statistics for this record